Trial Profile
A Split Body Study of the Effects of Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- 10 Jan 2021 Results published in the Journal of the American Academy of Dermatology
- 23 Aug 2019 Status changed from active, no longer recruiting to completed.
- 25 Mar 2019 Status changed from recruiting to active, no longer recruiting.